1 | TAC1, TACR1
|
| Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
|
| Li X, Ma G, Ma Q, Li W, Liu J, Han L, Duan W, Xu Q, Liu H, Wang Z, Sun Q, Wang F, Wu E.
|
| Mol Cancer Res 11(3):294-302. doi: 10.1158/1541-7786.MCR-12-0609. Epub 2013 Jan 23.
2013
|
2 | TAC1
|
| Substance P decreases fat storage and increases adipocytokine production in 3T3-L1 adipocytes.
|
| Miegueu P, St-Pierre DH, Lapointe M, Poursharifi P, Lu H, Gupta A, Cianflone K.
|
| Am J Physiol Gastrointest Liver Physiol 304(4):G420-7. doi: 10.1152/ajpgi.00162.2012. Epub 2012 Dec 20.
2013
|
3 | TAC1, TACR1
|
| Substance P-neurokinin-1 receptor interaction upregulates monocyte tissue factor.
|
| Khan MM, Douglas SD, Benton TD.
|
| J Neuroimmunol 242(1-2):1-8. doi: 10.1016/j.jneuroim.2011.10.012. Epub 2011 Nov 23.
2012
|
4 | TAC1, TACR1
|
| Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin action.
|
| Karagiannides I, Stavrakis D, Bakirtzi K, Kokkotou E, Pirtskhalava T, Nayeb-Hashemi H, Bowe C, Bugni JM, Nuņo M, Lu B, Gerard NP, Leeman SE, Kirkland JL, Pothoulakis C.
|
| Endocrinology 152(6):2197-205. doi: 10.1210/en.2010-1345. Epub 2011 Apr 5.
2011
|
5 | TAC1, TACR1
|
| Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.
|
| Douglas SD, Leeman SE.
|
| Ann N Y Acad Sci 1217:83-95. doi: 10.1111/j.1749-6632.2010.05826.x. Epub 2010 Nov 22. Review.
2011
|
6 | TAC1, TACR1
|
| Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
|
| Monaco-Shawver L, Schwartz L, Tuluc F, Guo CJ, Lai JP, Gunnam SM, Kilpatrick LE, Banerjee PP, Douglas SD, Orange JS.
|
| J Leukoc Biol 89(1):113-25. doi: 10.1189/jlb.0410200. Epub 2010 Oct 12.
2011
|
7 | MME, TAC1
|
| CD10-bearing fibroblasts may inhibit skin inflammation by down-modulating substance P.
|
| Xie L, Takahara M, Nakahara T, Oba J, Uchi H, Takeuchi S, Moroi Y, Furue M.
|
| Arch Dermatol Res 303(1):49-55. doi: 10.1007/s00403-010-1093-9. Epub 2010 Nov 13.
2011
|
8 | TAC1
|
| Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer.
|
| David S, Kan T, Cheng Y, Agarwal R, Jin Z, Mori Y.
|
| Biochem Biophys Res Commun 378(3):605-9. Epub 2008 Nov 29.
2009
|
9 | TAC1, TACR1
|
| Substance P and NK-1R expression in oral precancerous epithelium.
|
| Gonzalez-Moles MA, Brener S, Ruiz-Avila I, Gil-Montoya JA, Tostes D, Bravo M, Esteban F.
|
| Oncol Rep 22(6):1325-31.
2009
|
10 | TAC1
|
| Substance P mediates antiapoptotic responses in human colonocytes by Akt activation.
|
| Koon HW, Zhao D, Zhan Y, Moyer MP, Pothoulakis C.
|
| Proc Natl Acad Sci U S A 104(6):2013-8. Epub 2007 Jan 30. 2007
|
11 | TAC1
|
| Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study.
|
| Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, Hashimoto O, Nanba E, Nishida H, Sugiyama T, Kasai K, Watanabe K, Kano Y, Kato N, Sasaki T.
|
| Brain Dev 29(8):510-3. Epub 2007 Mar 21.
2007
|
12 | TAC1
|
| Transport of somatostatin and substance P by human P-glycoprotein.
|
| Uchiyama-Kokubu N, Naito M, Nakajima M, Tsuruo T.
|
| FEBS Lett 574(1-3):55-61. 2004
|
13 | TAC1
|
| Tachykinins regulate the function of platelets.
|
| Graham GJ, Stevens JM, Page NM, Grant AD, Brain SD, Lowry PJ, Gibbins JM.
|
| Blood 104(4):1058-65. Epub 2004 May 6. 2004
|
14 | TAC1
|
| Substance P in human tears.
|
| Yamada M, Ogata M, Kawai M, Mashima Y, Nishida T.
|
| Cornea 22(7 Suppl):S48-54. 2003
|
15 | TAC1
|
| Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis.
|
| Chiwakata C, et al.
|
| Endocrinology 128(5):2441-8. 1991
|
16 | TAC1
|
| RFLPs associated with the substance P-neurokinin A gene (NKNA).
|
| Miguel C de, et al.
|
| Nucleic Acids Res 16 : 1644. 1988
|
17 | TAC1, TAC3
|
| The chromosomal location of the two human tackykinin genes : human substance P and neurokinin K.
|
| Bonner TI, et al.
|
| (HGM9) Cytogenet Cell Genet 46 : 584. 1987
|